Dr. Sai Yendamuri is a thoracic surgeon who treats patients with lung cancer, pleural mesothelioma, and other thoracic malignancies using minimally invasive surgery at Roswell Park Comprehensive Cancer Center in Buffalo, New York. He is also the Chief of the Department of Thoracic Surgery. Education and Career Dr. Yendamuri’s education began at the All India
Dr. Brendon M. Stiles is a thoracic surgeon and Chief of Thoracic Surgery and Surgical Oncology at Montefiore Einstein Comprehensive Cancer Center in New York. He specializes in treating lung and esophageal cancers and unusual and rare thoracic cancers, including pleural mesothelioma. Dr. Stiles is also skilled in treating benign chest and upper gastrointestinal diseases
Dr. Balazs Halmos is a medical and thoracic oncologist at the Montefiore Einstein Comprehensive Cancer Center, where he serves as the Director of Thoracic Oncology. As one of three team leaders of the center’s lung cancer team, his clinical focus is on the management of patients with thoracic malignancies, including pleural mesothelioma and esophageal cancer.
Dr. Benjamin Medina is a thoracic surgeon at the Rutgers Cancer Institute of New Jersey and RWJBarnabas Health. He specializes in thoracic malignancies, including lung cancer and pleural mesothelioma, as well as esophageal cancer, mediastinal tumors, and chest wall tumors, using robotic and minimally invasive techniques that minimize pain, shorten hospital stays, and provide patients
Dr. Missak Haigentz is a thoracic oncologist at the Rutgers Cancer Institute and RWJBarnabas Health. Dr. Haigentz has focused his experience and knowledge on caring for patients with thoracic cancers, including cancer of the lung and thymus, pleural mesothelioma, and head and neck cancers. Education and Career Dr. Haigentz earned his medical degree at the UMDNJ-New
While malignant mesothelioma remains a fatal diagnosis, innovations in surgical techniques and other treatments have made a significant impact on overall survival and quality of life. A recent study conducted by researchers from Kaiser Permanente in Northern California confirmed that increased specialization of mesothelioma physicians and the use of bi-disciplinary tumor boards makes a significant
Dr. Konstantin H. Dragnev is a medical oncologist and renowned researcher at the Dartmouth Cancer Center. His principal clinical focus is on non-small cell and small cell lung cancer, pleural mesothelioma, esophageal cancer, and targeted therapies. He is currently the interim director of the Dartmouth Cancer Center and has been the medical director of its
Dr. Rian M. Hasson is a thoracic surgeon at Brigham and Women’s Hospital in Boston and a faculty member at Harvard Medical School. She works as part of a multidisciplinary team to treat patients diagnosed with a range of thoracic cancers and benign diseases, including lung cancer, pleural mesothelioma, esophageal cancer, and chest wall malignancies.
David J. Finley is a thoracic oncologist and the Director of Dartmouth Cancer Center’s Comprehensive Thoracic Oncology Program. He is skilled in a wide range of surgical techniques. He specializes in the treatment of patients with pleural mesothelioma, lung cancer, esophageal cancer, and other thoracic malignancies. Education and Career Dr. Finley attended Duke University as
Dr. Estelamari Rodriguez is a triple board-certified hematologist and oncologist, and internist at the University of Miami’s Sylvester Comprehensive Cancer Center. Her clinical interest is in the early detection and treatment of mesothelioma and lung cancer, as well as in developing programs to eradicate disparities in health care. Education and Career Dr. Rodriguez earned her